The University of Chicago Header Logo

Connection

Adam DuVall to Lymphoma, B-Cell

Back to Details
This is a "connection" page, showing publications Adam DuVall has written about Lymphoma, B-Cell.
Adam DuVall
Connection Strength
0.196
Lymphoma, B-Cell
  1. Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO Precis Oncol. 2022 10; 6:e2200353.
    View in: PubMed
    Score: 0.196
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.